Long-acting injectables are transforming schizophrenia treatment by ensuring medication adherence and reducing relapse rates.
After cannabis policy legalization, incident cases of schizophrenia linked to cannabis use disorder nearly tripled. Evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback